Nivatrotamab (Anti-CD3 & GD2)

製品コード：A4062        

印刷

Nivatrotamab is a humanized bispecific antibody targeting GD2 on tumor cells and CD3 on T cells to enhance immune activation. It is being developed for the treatment of metastatic small cell lung cancer (SCLC) by recruiting T cells to attack tumors. M. W 200.96 kDa

製品説明

CAS No. N/A
Source CHO
Storage
(From the date of receipt)		 -80℃(avoid freeze-thaw cycles)
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。